Clinical Trial Update: Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis. [Phase 3]

View source ↗

Summary

Phase III multicentre trial of oral mesalazine in patients with mild to moderate ulcerative colitis is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Mesalazine (mesalazine)

Snippet

Sponsor: Faes Farma, S.A. | Conditions: Colitis, Ulcerative | Phase 3 | Status: UNKNOWN